Summary
- Current Price
- As of today, BMY price is $60.59, up +5.21% on
- Current Price All-Time High
- BMY price is currently -25.60% below its historical high of $81.44 set on
- Market Cap
- BMY current market cap is $124B, up +21.09% over the past 365 days
- PE Ratio
- BMY current PE ratio is 17.52
- Revenue
- BMY current annual revenue is $48.19B, down -0.22% year-over-year
- Next Earnings
- As of today, the next earnings release for BMY has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Bristol-Myers Squibb Company |
| Ticker | NYSE: BMY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | bms.com |
| Employees | 34,100 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $60.59 | |
| Price, 1D Change | +5.21% | |
| Market Cap | $124B | |
| TTM Dividend Yield | 4.13% | |
| PE Ratio | 17.52 | |
| Beta | 0.50 | |
| Revenue | $48B | |
| Revenue, 1Y Change | -0.22% | |
| EPS | $3.46 | |
| EPS, 1Y Change | +178.37% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.63 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1000000:951777 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $3.46 | |
| EPS Estimate | N/A | $6.26 |
| EPS Est. Change | N/A | +81.02% |
| Revenue | $48.19B | |
| Revenue Estimate | N/A | $47.12B |
| Revenue Est. Change | N/A | -2.23% |
| Current Price | $60.59 | |
| Price Target | - | $64.00 |
| Price Tgt. Change | - | +5.63% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.92 | -$4.41 | -580.82% | |
| $6.14 | $3.46 | -43.62% | |
| $6.26 | N/A | +81.02% | |
| $6.13 | N/A | +77.25% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $47.51B | $48.30B | +1.66% | |
| $47.99B | $48.19B | +0.43% | |
| $47.12B | N/A | -2.23% | |
| $46.02B | N/A | -4.50% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +20.70% | |
| Price, 3Y | -9.26% | |
| Market Cap, 1Y | +21.09% | |
| Market Cap, 3Y | -11.81% | |
| Revenue, 1Y | -0.22% | |
| Revenue, 3Y | +4.41% | |
| EPS, 1Y | +178.37% | |
| EPS, 3Y | +17.34% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $60.59 | |
| SMA 200 | $51.95 | |
| SMA 200 vs Price | -14.26% | |
| SMA 50 | $59.57 | |
| SMA 50 vs Price | -1.69% | |
| Beta | 0.50 | |
| ATR | $1.42 | |
| 14-Day RSI | 57.28 | |
| 10-Day Volatility | 33.13% | |
| 1-Year Volatility | 28.03% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.63 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 4.09% | |
| Total Dividend | $2.48 | |
| Dividends Paid | $5.05B | |
| Payout Ratio | 71.50% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $48.19B | |
| EPS | $3.46 | |
| Gross Profit | $34.95B | |
| Gross Margin | 72.52% | |
| Operating Profit | $14.99B | |
| Operating Margin | 31.11% | |
| Net Income | $7.06B | |
| Net Margin | 14.64% | |
| EBITDA | $19.24B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 2.55 | |
| Current Ratio | 1.26 | |
| Quick Ratio | 1.14 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 2.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 17.52 | |
| PS Ratio | 2.57 | |
| PB Ratio | 6.70 | |
| EV/EBITDA | 8.33 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $18.47B | |
| Cash & Equivalents | $10.67B | |
| Total Assets | $90.04B | |
| Current Assets | $29.39B | |
| Total Liabilities | $71.53B | |
| Current Liabilities | $23.42B | |
| Total Debt | $45.11B | |
| Short Term Debt | $2.26B | |
| Accounts Payable | $3.58B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $41.14B | |
| Operating Expenses | $19.96B | |
| Cost Of Goods Sold | $13.25B | |
| SG&A | $0.00 | |
| D&A | $4.01B | |
| Interest Expense | $0.00 | |
| Income Tax | $2.27B |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $14.16B | |
| CFI | -$4.13B | |
| CFF | -$10.35B | |
| Capex | $1.31B | |
| Free Cash Flow | $12.85B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B of A Securities | → | |
| Guggenheim | → | |
| Cantor Fitzgerald | → | |
| HSBC | → | |
| RBC Capital | ||
| Piper Sandler | → | |
| Barclays | ||
| Wells Fargo | → | |
| Guggenheim | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with BMY
FAQ
What is the ticker symbol for Bristol-Myers Squibb Company?
The ticker symbol for Bristol-Myers Squibb Company is NYSE:BMY
Does Bristol-Myers Squibb Company pay dividends?
Yes, Bristol-Myers Squibb Company pays dividends. The last payment was $0.63, with an ex-dividend date on April 1, 2026
What sector is Bristol-Myers Squibb Company in?
Bristol-Myers Squibb Company is in the Healthcare sector
What industry is Bristol-Myers Squibb Company in?
Bristol-Myers Squibb Company is in the General Drug Manufacturers industry
What country is Bristol-Myers Squibb Company based in?
Bristol-Myers Squibb Company is headquartered in United States
When did Bristol-Myers Squibb Company go public?
Bristol-Myers Squibb Company initial public offering (IPO) was on June 1, 1972
Is Bristol-Myers Squibb Company in the S&P 500?
Yes, Bristol-Myers Squibb Company is included in the S&P 500 index
Is Bristol-Myers Squibb Company in the NASDAQ 100?
No, Bristol-Myers Squibb Company is not included in the NASDAQ 100 index
Is Bristol-Myers Squibb Company in the Dow Jones?
No, Bristol-Myers Squibb Company is not included in the Dow Jones index
When was Bristol-Myers Squibb Company last earnings report?
Bristol-Myers Squibb Company's most recent earnings report was on April 30, 2026
When does Bristol-Myers Squibb Company report earnings?
The date for Bristol-Myers Squibb Company's next earnings report has not been announced yet
Data Sources & References
- BMY Official Website www.bms.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/14272/000001427226000002/0000014272-26-000002-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/14272/000001427226000004/0000014272-26-000004-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- BMY Profile on Yahoo Finance finance.yahoo.com/quote/BMY
- BMY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bmy
